Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pharmacological management of migraine, part 1: overview and abortive therapy.

Literature DB >> 19750119

The pharmacological management of migraine, part 1: overview and abortive therapy.

Abstract

Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.

Entities: Disease

Year: 2008 PMID： 19750119 PMCID： PMC2740949

Source DB: PubMed Journal: P T ISSN： 1052-1372

227 in total

Review 1. Over-the-counter drugs for acute migraine attacks: literature review and recommendations.

Authors: Richard G Wenzel; Carrie A Sarvis; Michelle L Krause
Journal: Pharmacotherapy Date: 2003-04 Impact factor: 4.705

2. Emergency treatment of intractable migraine.

Authors: R M Gallagher
Journal: Headache Date: 1986-02 Impact factor: 5.887

3. The prevention and treatment of migraine with an analgesic combination.

Authors: R L Carasso; S Yehuda
Journal: Br J Clin Pract Date: 1984-01

4. Droperidol treatment of status migrainosus and refractory migraine.

Authors: S J Wang; S D Silberstein; W B Young
Journal: Headache Date: 1997-06 Impact factor: 5.887

Review 5. Non-oral formulations of triptans and their use in acute migraine.

Authors: Carl G H Dahlöf
Journal: Curr Pain Headache Rep Date: 2005-06

6. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.

Authors: M G Buzzi; M A Moskowitz
Journal: Br J Pharmacol Date: 1990-01 Impact factor: 8.739

7. Drug induced refractory headache--clinical features and management.

Authors: N T Mathew; R Kurman; F Perez
Journal: Headache Date: 1990-10 Impact factor: 5.887

8. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.

Authors: Hans-Christoph Diener; Astrid Gendolla; Irmingard Gebert; Manfred Beneke
Journal: Headache Date: 2005 Jul-Aug Impact factor: 5.887

9. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination.

Authors: J Sensenig; M Johnson; T Staverosky
Journal: Altern Med Rev Date: 2001-10

10. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor.

Authors: I Jansen; L Edvinsson; A Mortensen; J Olesen
Journal: Cephalalgia Date: 1992-08 Impact factor: 6.292

3 in total

1. Effect of Different Meditation Types on Migraine Headache Medication Use.

Authors: Amy B Wachholtz; Christopher D Malone; Kenneth I Pargament
Journal: Behav Med Date: 2015-04-11 Impact factor: 3.104

2. Migraine: treatments, comorbidities, and quality of life, in the USA.

Authors: Christopher D Malone; Amrita Bhowmick; Amy B Wachholtz
Journal: J Pain Res Date: 2015-08-12 Impact factor: 3.133

3. Comparative efficacy trial of cupping and serkangabin versus conventional therapy of migraine headaches: A randomized, open-label, comparative efficacy trial.

Authors: Mohammad Dehghani Firoozabadi; Maryam Navabzadeh; Mohammad Khodashenas Roudsari; Mohsen Zahmatkash
Journal: J Res Med Sci Date: 2014-12 Impact factor: 1.852

3 in total